Europe’s medicines regulator added a rare nerve-degenerating disorder, Guillain-Barré syndrome, as a possible rare side effect from Johnson & Johnson’s Covid-19 vaccine after the European Medicines Agency reviewed 108 cases reported worldwide.
The U.S. Food and Drug Administration is planning a new warning for Johnson & Johnson’s Covid-19 vaccine over a rare but serious side effect, Guillain-Barré syndrome (GBS).
South San Francisco-based Annexon, focused on drugs for autoimmune and neurodegenerative disorders, closed on a $100 million Series C financing led by Redmile Group.
The United States is likely to see outbreaks of the Zika virus, with perhaps dozens or scores of people affected, said Dr. Anthony Fauci, director of the U.S. National Institute […]
Scientists in Brazil have uncovered a new brain disorder associated with Zika infections in adults: an autoimmune syndrome called acute disseminated encephalomyelitis, or ADEM, that attacks the brain and spinal […]
French scientists say they have proved a link between the Zika virus and a nerve syndrome called Guillain-Barre, suggesting countries hit by the Zika epidemic will see a rise in […]
BARCELONA (Thomson Reuters Foundation) – In the Caribbean island state of Barbados, rainwater collection has been promoted as a way to boost scarce supplies of fresh water. But there’s a […]